Arcellx (ACLX) Cash from Investing Activities (2021 - 2025)

Arcellx's (ACLX) quarterly Cash from Investing Activities came in at $57.8 million in Q4 2025, up 1502.86% year-on-year from $3.6 million in Q4 2024, and up 388.61% quarter-over-quarter from -$20.0 million in Q3 2025.

Arcellx (ACLX) Cash from Investing Activities (2021 - 2025) Analysis & Trends

Arcellx's Cash from Investing Activities history runs 5 years deep, the most recent figure standing at $57.8 million for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities rose 1502.86% year-over-year to $57.8 million in Q4 2025; TTM through Dec 2025 was $86.3 million, a 147.15% increase from a year earlier, with the FY2025 full-year figure at $86.3 million, up 147.15% from the prior year.
  • Cash from Investing Activities improved to $57.8 million in Q4 2025 per ACLX's latest filing, from -$20.0 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $57.8 million in Q4 2025 and bottomed at -$206.8 million in Q1 2024.
  • The 5-year median for Cash from Investing Activities is -$6.0 million (2024), against an average of -$22.4 million.
  • Across the five-year window, Cash from Investing Activities sank 32807.22% in 2022 and surged 1502.86% in 2025, its largest moves.
  • Year by year, Cash from Investing Activities stood at -$17.7 million in 2021, then jumped by 290.35% to $33.6 million in 2022, then slumped by 37.49% to $21.0 million in 2023, then tumbled by 119.6% to -$4.1 million in 2024, then surged by 1502.86% to $57.8 million in 2025.
  • Per Business Quant, the three latest ACLX Cash from Investing Activities figures stand at $57.8 million (Q4 2025), -$20.0 million (Q3 2025), and $10.7 million (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -45.51 Mn
4 NuCana 279.75 Bn 279.75 Bn - 178,242.27
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -431.90 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -428.90 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 172.62 Mn
10 Arcellx 6.48 Bn 6.48 Bn - 57.80 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 57.80 Mn
Dec 31, 2025 57.80 Mn
Sep 30, 2025 -20.03 Mn
Sep 30, 2025 -20.03 Mn
Jun 30, 2025 10.74 Mn
Jun 30, 2025 10.74 Mn
Mar 31, 2025 37.78 Mn
Mar 31, 2025 37.78 Mn
Dec 31, 2024 -4.12 Mn
Dec 31, 2024 -4.12 Mn
Sep 30, 2024 35.76 Mn
Sep 30, 2024 35.76 Mn
Jun 30, 2024 -7.87 Mn
Jun 30, 2024 -7.87 Mn
Mar 31, 2024 -206.81 Mn
Mar 31, 2024 -206.81 Mn
Dec 31, 2023 21.02 Mn
Dec 31, 2023 21.02 Mn
Sep 30, 2023 -160.03 Mn
Sep 30, 2023 -160.03 Mn